BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism

  • Lee, Ho-Jae (Department of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine) ;
  • Cha, Ji-Young (Department of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine)
  • Received : 2018.07.27
  • Published : 2018.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Fructose in the form of sucrose and high fructose corn syrup is absorbed by the intestinal transporter and mainly metabolized in the small intestine. However, excess intake of fructose overwhelms the absorptive capacity of the small intestine, leading to fructose malabsorption. Carbohydrate response element-binding protein (ChREBP) is a basic helix-loop-helix leucine zipper transcription factor that plays a key role in glycolytic and lipogenic gene expression in response to carbohydrate consumption. While ChREBP was initially identified as a glucose-responsive factor in the liver, recent evidence suggests that ChREBP is essential for fructose-induced lipogenesis and gluconeogenesis in the small intestine as well as in the liver. We recently identified that the loss of ChREBP leads to fructose intolerance via insufficient induction of genes involved in fructose transport and metabolism in the intestine. As fructose consumption is increasing and closely associated with metabolic and gastrointestinal diseases, a comprehensive understanding of cellular fructose sensing and metabolism via ChREBP may uncover new therapeutic opportunities. In this mini review, we briefly summarize recent progress in intestinal fructose metabolism, regulation and function of ChREBP by fructose, and delineate the potential mechanisms by which excessive fructose consumption may lead to irritable bowel syndrome.

Keywords

References

  1. Hanover LM and White JS (1993) Manufacturing, composition, and applications of fructose. Am J Clin Nutr 58, 724S-732S https://doi.org/10.1093/ajcn/58.5.724S
  2. Bray GA, Nielsen SJ and Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79, 537-543 https://doi.org/10.1093/ajcn/79.4.537
  3. Powell ES, Smith-Taillie LP and Popkin BM (2016) Added Sugars Intake Across the Distribution of US Children and Adult Consumers: 1977-2012. J Acad Nutr Diet 116, 1543-1550 e1541 https://doi.org/10.1016/j.jand.2016.06.003
  4. Lee H-S, Kwon S-o, Yon M et al (2014) Dietary total sugar intake of Koreans: Based on the Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2011. J Nutr Health 47, 268-276 https://doi.org/10.4163/jnh.2014.47.4.268
  5. Elliott SS, Keim NL, Stern JS, Teff K and Havel PJ (2002) Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76, 911-922 https://doi.org/10.1093/ajcn/76.5.911
  6. Haidari M, Leung N, Mahbub F et al (2002) Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem 277, 31646-31655 https://doi.org/10.1074/jbc.M200544200
  7. Stanhope KL (2012) Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome. Annu Rev Med 63, 329-343 https://doi.org/10.1146/annurev-med-042010-113026
  8. Jones HF, Butler RN and Brooks DA (2011) Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol 300, G202-206 https://doi.org/10.1152/ajpgi.00457.2010
  9. Heizer WD, Southern S and McGovern S (2009) The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review. J Am Diet Assoc 109, 1204-1214 https://doi.org/10.1016/j.jada.2009.04.012
  10. Le KA, Ith M, Kreis R et al (2009) Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 89, 1760-1765 https://doi.org/10.3945/ajcn.2008.27336
  11. Thorens B and Mueckler M (2010) Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 298, E141-145 https://doi.org/10.1152/ajpendo.00712.2009
  12. Burant CF, Takeda J, Brot-Laroche E, Bell GI and Davidson NO (1992) Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem 267, 14523-14526
  13. Corpe CP, Burant CF and Hoekstra JH (1999) Intestinal fructose absorption: clinical and molecular aspects. J Pediatr Gastroenterol Nutr 28, 364-374 https://doi.org/10.1097/00005176-199904000-00004
  14. Castello A, Guma A, Sevilla L et al (1995) Regulation of GLUT5 gene expression in rat intestinal mucosa: regional distribution, circadian rhythm, perinatal development and effect of diabetes. Biochem J 309, 271-277 https://doi.org/10.1042/bj3090271
  15. Blakemore SJ, Aledo JC, James J, Campbell FC, Lucocq JM and Hundal HS (1995) The GLUT5 hexose transporter is also localized to the basolateral membrane of the human jejunum. Biochem J 309, 7-12 https://doi.org/10.1042/bj3090007
  16. Jang C, Hui S, Lu W et al (2018) The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids. Cell Metab 27, 351-361 e353 https://doi.org/10.1016/j.cmet.2017.12.016
  17. Ferraris RP, Yasharpour S, Lloyd KC, Mirzayan R and Diamond JM (1990) Luminal glucose concentrations in the gut under normal conditions. Am J Physiol 259, G822-837
  18. Patel C, Sugimoto K, Douard V et al (2015) Effect of dietary fructose on portal and systemic serum fructose levels in rats and in KHK-/- and GLUT5-/- mice. Am J Physiol Gastrointest Liver Physiol 309, G779-790 https://doi.org/10.1152/ajpgi.00188.2015
  19. Douard V and Ferraris RP (2008) Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab 295, E227-237 https://doi.org/10.1152/ajpendo.90245.2008
  20. Gorboulev V, Schurmann A, Vallon V et al (2012) Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61, 187-196 https://doi.org/10.2337/db11-1029
  21. Woods HF, Eggleston LV and Krebs HA (1970) The cause of hepatic accumulation of fructose 1-phosphate on fructose loading. Biochem J 119, 501-510 https://doi.org/10.1042/bj1190501
  22. van den Berghe G, Bronfman M, Vanneste R and Hers HG (1977) The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase. Biochem J 162, 601-609 https://doi.org/10.1042/bj1620601
  23. Yun Y, Yin H, Gao Z et al (2017) Intestinal tract is an important organ for lowering serum uric acid in rats. PLoS One 12, e0190194 https://doi.org/10.1371/journal.pone.0190194
  24. Diggle CP, Shires M, McRae C et al (2010) Both isoforms of ketohexokinase are dispensable for normal growth and development. Physiol Genomics 42A, 235-243 https://doi.org/10.1152/physiolgenomics.00128.2010
  25. Ishimoto T, Lanaspa MA, Le MT et al (2012) Opposing effects of fructokinase C and A isoforms on fructoseinduced metabolic syndrome in mice. Proc Natl Acad Sci U S A 109, 4320-4325 https://doi.org/10.1073/pnas.1119908109
  26. Mayes PA (1993) Intermediary metabolism of fructose. Am J Clin Nutr 58, 754S-765S https://doi.org/10.1093/ajcn/58.5.754S
  27. Heinz F, Lamprecht W and Kirsch J (1968) Enzymes of fructose metabolism in human liver. J Clin Invest 47, 1826-1832 https://doi.org/10.1172/JCI105872
  28. Sun SZ and Empie MW (2012) Fructose metabolism in humans - what isotopic tracer studies tell us. Nutr Metab (Lond) 9, 89 https://doi.org/10.1186/1743-7075-9-89
  29. Douard V and Ferraris RP (2013) The role of fructose transporters in diseases linked to excessive fructose intake. J Physiol 591, 401-414 https://doi.org/10.1113/jphysiol.2011.215731
  30. de Luis O, Valero MC and Jurado LA (2000) WBSCR14, a putative transcription factor gene deleted in Williams-Beuren syndrome: complete characterisation of the human gene and the mouse ortholog. Eur J Hum Genet 8, 215-222 https://doi.org/10.1038/sj.ejhg.5200435
  31. Yamashita H, Takenoshita M, Sakurai M et al (2001) A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 98, 9116-9121 https://doi.org/10.1073/pnas.161284298
  32. Shih HM, Liu Z and Towle HC (1995) Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J Biol Chem 270, 21991-21997 https://doi.org/10.1074/jbc.270.37.21991
  33. Stoeckman AK, Ma L and Towle HC (2004) Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. J Biol Chem 279, 15662-15669 https://doi.org/10.1074/jbc.M311301200
  34. Ma L, Robinson LN and Towle HC (2006) ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem 281, 28721-28730 https://doi.org/10.1074/jbc.M601576200
  35. Kawaguchi T, Takenoshita M, Kabashima T and Uyeda K (2001) Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A 98, 13710-13715 https://doi.org/10.1073/pnas.231370798
  36. Kawaguchi T, Osatomi K, Yamashita H, Kabashima T and Uyeda K (2002) Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMPactivated protein kinase. J Biol Chem 277, 3829-3835 https://doi.org/10.1074/jbc.M107895200
  37. Sato S, Jung H, Nakagawa T et al (2016) Metabolite Regulation of Nuclear Localization of Carbohydrateresponse Element-binding Protein (ChREBP): ROLE OF AMP AS AN ALLOSTERIC INHIBITOR. J Biol Chem 291, 10515-10527 https://doi.org/10.1074/jbc.M115.708982
  38. Dentin R, Tomas-Cobos L, Foufelle F et al (2012) Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J Hepatol 56, 199-209 https://doi.org/10.1016/j.jhep.2011.07.019
  39. Kabashima T, Kawaguchi T, Wadzinski BE and Uyeda K (2003) Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A 100, 5107-5112 https://doi.org/10.1073/pnas.0730817100
  40. Iizuka K, Wu W, Horikawa Y and Takeda J (2013) Role of glucose-6-phosphate and xylulose-5-phosphate in the regulation of glucose-stimulated gene expression in the pancreatic beta cell line, INS-1E. Endocr J 60, 473-482
  41. Arden C, Tudhope SJ, Petrie JL et al (2012) Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochem J 443, 111-123 https://doi.org/10.1042/BJ20111280
  42. Herman MA, Peroni OD, Villoria J et al (2012) A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 484, 333-338 https://doi.org/10.1038/nature10986
  43. Li MV, Chang B, Imamura M, Poungvarin N and Chan L (2006) Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. Diabetes 55, 1179-1189 https://doi.org/10.2337/db05-0822
  44. Sakiyama H, Wynn RM, Lee WR et al (2008) Regulation of nuclear import/export of carbohydrate response element-binding protein (ChREBP): interaction of an alpha-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation. J Biol Chem 283, 24899-24908 https://doi.org/10.1074/jbc.M804308200
  45. Fukasawa M, Ge Q, Wynn RM, Ishii S and Uyeda K (2010) Coordinate regulation/localization of the carbohydrate responsive binding protein (ChREBP) by two nuclear export signal sites: discovery of a new leucine-rich nuclear export signal site. Biochem Biophys Res Commun 391, 1166-1169 https://doi.org/10.1016/j.bbrc.2009.11.115
  46. Ge Q, Nakagawa T, Wynn RM, Chook YM, Miller BC and Uyeda K (2011) Importin-alpha protein binding to a nuclear localization signal of carbohydrate response element-binding protein (ChREBP). J Biol Chem 286, 28119-28127 https://doi.org/10.1074/jbc.M111.237016
  47. Bricambert J, Miranda J, Benhamed F, Girard J, Postic C and Dentin R (2010) Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest 120, 4316-4331 https://doi.org/10.1172/JCI41624
  48. Guinez C, Filhoulaud G, Rayah-Benhamed F et al (2011) O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 60, 1399-1413 https://doi.org/10.2337/db10-0452
  49. Ido-Kitamura Y, Sasaki T, Kobayashi M et al (2012) Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation. PLoS One 7, e47231 https://doi.org/10.1371/journal.pone.0047231
  50. Koo HY, Miyashita M, Cho BH and Nakamura MT (2009) Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus. Biochem Biophys Res Commun 390, 285-289 https://doi.org/10.1016/j.bbrc.2009.09.109
  51. Lanaspa MA, Sanchez-Lozada LG, Cicerchi C et al (2012) Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS One 7, e47948 https://doi.org/10.1371/journal.pone.0047948
  52. Kim MS, Krawczyk SA, Doridot L et al (2016) ChREBP regulates fructose-induced glucose production independently of insulin signaling. J Clin Invest 126, 4372-4386 https://doi.org/10.1172/JCI81993
  53. Kim M, Astapova II, Flier SN et al (2017) Intestinal, but not hepatic, ChREBP is required for fructose tolerance. JCI Insight 2, e96703 https://doi.org/10.1172/jci.insight.96703
  54. Oh AR, Sohn S, Lee J et al (2018) ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome. Metabolism 85, 286-297 https://doi.org/10.1016/j.metabol.2018.04.006
  55. Iizuka K, Bruick RK, Liang G, Horton JD and Uyeda K (2004) Deficiency of carbohydrate response elementbinding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci U S A 101, 7281-7286 https://doi.org/10.1073/pnas.0401516101
  56. Uyeda K and Repa JJ (2006) Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab 4, 107-110 https://doi.org/10.1016/j.cmet.2006.06.008
  57. Jeong YS, Kim D, Lee YS et al (2011) Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucoseregulated gene expression. PLoS One 6, e22544 https://doi.org/10.1371/journal.pone.0022544
  58. Poungvarin N, Chang B, Imamura M et al (2015) Genome-Wide Analysis of ChREBP Binding Sites on Male Mouse Liver and White Adipose Chromatin. Endocrinology 156, 1982-1994 https://doi.org/10.1210/en.2014-1666
  59. Bae JS, Oh AR, Lee HJ, Ahn YH and Cha JY (2016) Hepatic Elovl6 gene expression is regulated by the synergistic action of ChREBP and SREBP-1c. Biochem Biophys Res Commun 478, 1060-1066 https://doi.org/10.1016/j.bbrc.2016.08.061
  60. Iizuka K, Takeda J and Horikawa Y (2009) Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes. FEBS Lett 583, 2882-2886 https://doi.org/10.1016/j.febslet.2009.07.053
  61. Pedersen KB, Zhang P, Doumen C et al (2007) The promoter for the gene encoding the catalytic subunit of rat glucose-6-phosphatase contains two distinct glucoseresponsive regions. Am J Physiol Endocrinol Metab 292, E788-801 https://doi.org/10.1152/ajpendo.00510.2006
  62. Shin E, Bae JS, Han JY et al (2016) Hepatic DGAT2 gene expression is regulated by the synergistic action of ChREBP and SP1 in HepG2 cells. Anim Cells Syst 20, 7-14 https://doi.org/10.1080/19768354.2015.1131738
  63. Iizuka K, Tomita R, Takeda J and Horikawa Y (2012) Rat glucagon receptor mRNA is directly regulated by glucose through transactivation of the carbohydrate response element binding protein. Biochem Biophys Res Commun 417, 1107-1112 https://doi.org/10.1016/j.bbrc.2011.12.042
  64. Noordeen NA, Khera TK, Sun G et al (2010) Carbohydrateresponsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1beta gene expression in pancreatic islet beta-cells. Diabetes 59, 153-160 https://doi.org/10.2337/db08-0868
  65. Boergesen M, Poulsen L, Schmidt SF, Frigerio F, Maechler P and Mandrup S (2011) ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells. J Biol Chem 286, 13214-13225 https://doi.org/10.1074/jbc.M110.215467
  66. Fisher FM, Kim M, Doridot L et al (2017) A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. Mol Metab 6, 14-21 https://doi.org/10.1016/j.molmet.2016.11.008
  67. Barone S, Fussell SL, Singh AK et al (2009) Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension. J Biol Chem 284, 5056-5066 https://doi.org/10.1074/jbc.M808128200
  68. Patel C, Douard V, Yu S, Tharabenjasin P, Gao N and Ferraris RP (2015) Fructose-induced increases in expression of intestinal fructolytic and gluconeogenic genes are regulated by GLUT5 and KHK. Am J Physiol Regul Integr Comp Physiol 309, R499-509 https://doi.org/10.1152/ajpregu.00128.2015
  69. Kato T, Iizuka K, Takao K, Horikawa Y, Kitamura T and Takeda J (2018) ChREBP-Knockout Mice Show Sucrose Intolerance and Fructose Malabsorption. Nutrients 10, 340 https://doi.org/10.3390/nu10030340
  70. Camilleri M (2001) Management of the irritable bowel syndrome. Gastroenterology 120, 652-668 https://doi.org/10.1053/gast.2001.21908
  71. Riby JE, Fujisawa T and Kretchmer N (1993) Fructose absorption. Am J Clin Nutr 58, 748S-753S https://doi.org/10.1093/ajcn/58.5.748S
  72. Gibson PR, Newnham E, Barrett JS, Shepherd SJ and Muir JG (2007) Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 25, 349-363
  73. Andersson DE and Nygren A (1978) Four cases of long-standing diarrhoea and colic pains cured by fructosefree diet--a pathogenetic discussion. Acta Med Scand 203, 87-92
  74. Ravich WJ, Bayless TM and Thomas M (1983) Fructose: incomplete intestinal absorption in humans. Gastroenterology 84, 26-29
  75. Rumessen JJ and Gudmand-Hoyer E (1988) Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology 95, 694-700 https://doi.org/10.1016/S0016-5085(88)80016-7
  76. Choi YK, Johlin FC Jr, Summers RW, Jackson M and Rao SS (2003) Fructose intolerance: an under-recognized problem. Am J Gastroenterol 98, 1348-1353 https://doi.org/10.1111/j.1572-0241.2003.07476.x